Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Effects of Mori Ramulus on Collagen-induced Arthritis Rat - Expression of Immunocells in Draining Lymph Node -

상지가 콜라겐 유발 관절염 랫트에 미치는 영향 - 배액림프절의 면역세포 발현 -

  • Roh, Seong-Soo (Laboratory of Herbology, College of Oriental Medicine, Daegu Haany University) ;
  • Ku, Sae-Kwang (Department of Anatomy & Histology, College of Oriental Medicine, Daegu Haany University) ;
  • Seo, Young-Bae (Department of Herbalogy, College of Oriental Medicine, Daejeon University)
  • 노성수 (대구한의대학교 한의과대학 본초학연구실) ;
  • 구세광 (대구한의대학교 한의과대학 해부조직학교실) ;
  • 서영배 (대전대학교 한의과대학 본초학교실)
  • Published : 2009.10.25
Download PDF
⟨ Previous Next ⟩

Abstract

Mori Ramulus has multiple applications in Korean traditional medicine prescription because it has antioxidant and anti-inflammatory effects by reducing macrophage activities. Yet, no studies on the anti-arthritic activity of EMR (extract of Mori Ramulus) have been reported in vitro and in vivo. Rheumatoid arthritis (RA) is a systemic autoimmune disease with chronic inflammation characterized by hyperplasia of synovial cells in affected joints, which ultimately leads to the destruction of cartilage and bone. Because collagen-induced arthritis (CIA) is similar to RA in pathological symptoms and immune reactions, there have been several reports concerning RA using CIA mouse model. Here, we investigated the effects of Mori Ramulus on RA using CIA mice. The importance of CD4+ Th1 cells in RA progress was previously indicated and studies further showed that Th17 cells play a prime role in severity of disease. Accordingly, the present study was focused on CIA associated with CD4+ Th1 cells and Th1 7 cells. DBA/1OlaHsd mice were immunized with bovine type II collagen (CII). After a second collagen immunization, mice were treated with EMR once a day for 4 weeks. The severity of arthritis within the paw joints was evaluated by histological assessment of cartilage destruction and pannus formation. Immune cells in peripheral blood mononuclear cells (PBMC), draining lymph node (DLN) and paw joints, cytokine production and gene expression were assessed from CIA mouse using ELISA, FACS and real-time PCR analysis. Administration of EMR significantly suppressed the progression of CIA and inhibited the production of TNF-$\alpha$, IL-6 and IL-17 in the serum. The erosion of cartilage was dramatically reduced in mouse knees after treatment with EMR. In conclusion, our results demonstrate that EMR significantly suppressed the progression of CIA and that this action was mediated by the decreased production of TNF-$\alpha$, IL-6, IL-17 and collagen II-specific antibody in the serum. EMR suppressed Th17 cells and reduced level of IL-6 via B cell suppression, and thus, the levels of autoantibodies produced from B cells were decreased. Furthermore, EMR suppressed NKT cells which directly stimulate B cells and develop imbalance of Th1/Th2 cell. Oral administration of EMR (100 mg/kg or 200 mg/kg) significantly suppressed the progression of CIA, which is comparable to that of methotrexate (MTX, 0.3 mg/kg) used as a positive control. We are currently studying the mechanism underlying the therapeutic role for EMR in CIA mice.

Keywords

References

  1. 식품의약안전청. 대한약전외생약규격집. 서울, 식품의약안전청, p 209, 2006
  2. 蘇頌編選, 尙志鈞輯校. 本草圖經. 合肥, 安徽科學技術出版社, p 380, 1986
  3. <中華本草> 編委會. 中華本草. 上海, 上海科學技術出版社, pp 530-531, 1999
  4. 顔正華. 中藥學. 北京, 人民衛生出版社, pp 694-695, 1991
  5. 肖培根主著. 新編中藥志. 北京, 化學工業出版社, pp 661-663, 2002
  6. 雷載權, 張廷模主編. 中華臨床中藥學. 北京, 人民衛生出版社, pp 762-764, 1999
  7. 辛民敎. 臨床本草學. 서울, 永林社, pp 246-247, 2000
  8. 冉先德主編. 中華藥海. 北京, 哈爾濱出版社, pp 689-691, 1996
  9. 徐國均. 何宏賢主, 徐珞珊, 金蓉鸞編. 中國藥材學. 北京, 中國醫藥科技出版社, pp 707-709, 1996
  10. 徐國均. 藥材學. 北京, 人民衛生出版社, p 215, 1963
  11. 王浴生主編. 中藥藥理及應用. 北京, 人民衛生出版社, p 925, 1983
  12. J. Galvez, G. Coelho, M.E. Crespo, T. Cruz, M.E. Rodriguez, A. Concha, M. Gonzalez. Intestinal anti-inflammatory activity of morin on chronic experimental colitis in the rat. Alimentary Pharmacology & Therapeutics. 15(12):2027-2039, 2001 https://doi.org/10.1046/j.1365-2036.2001.01133.x
  13. Lisu Wang, Yi-Chen Tu, Tzi-Wei Lian, Jing-Ting Hung, Jui-Hung Yen, and Ming-Jiuan Wu. Distinctive Antioxidant and Antiinflammatory Effects of Flavonols. J. Agric. Food Chem. 54(26):9798-9804, 2006 https://doi.org/10.1021/jf0620719
  14. Fang, S.H., Hou, Y.C., Chang, W.C., Hsiu, S.L.. Lee Chao, PD. Chiang, B.L. Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life sciences. 74(6):743-756, 2003 https://doi.org/10.1016/j.lfs.2003.07.017
  15. Vaghasiya, R.G., Banerjee, A., Shrivastava, N., Nivsarkar, M. Analgesic and Anti-inflammatory Activity of Hydroalcoholic Extract of Morus Alba Linne. Indian drugs. 44(5):364-367, 2007
  16. Ye, F., Shen, Z.F., Qiao, F.X., Zhao, D.Y., Xie, M.Z. Experimental Treatment of Complications in Alloxan Diabetic Rats with &alpha；-Glucosidase Inhibitor from the Chinese Medicinal Herb Ramulus mori. Acta pharmaceutica sinica. 37(2):108-112, 2002
  17. Peter Schenck, Stefan Schneider, Rolf Miehlke and Peter Prehm. Synthesis and degradation of hyaluronate by synovia from patients with rheumatoid arthritis. J. Rheumatol. 22: 400-405, 1995
  18. 제정진. 血府逐瘀湯이 Adjuvant 유발 관절염에 미치는 영향. 경희대학교 대학원, 1993
  19. 方藥中, 李克光, 鄧鐵濤, 金壽山, 黃星垣, 董建華 等編. 實用中醫內科學. 서울, 醫聖堂, pp 558-559, 1993
  20. 金穆鉉. 류머티양 관절염의 역학. 대한의학협회지, 29(1):7-10, 1986
  21. M. Feldmann, F.M. Brennan and R.N. Maini. Rheumatoid arthritis. Cell. 85: 307-310, 1996 https://doi.org/10.1016/S0092-8674(00)81109-5
  22. F. Wolfe and D.J. Hawley. The longterm outcomes of rheumatoid arthritis： work disability：a prospective 18 year study of 823 patients. Journal of Rheumatology. 25: 2108-2117, 1998
  23. Breedveld, F.C. New insights in the pathogenesis of rheumatoid arthritis. J Rheumatol Suppl. 53: 3-7, 1998
  24. Koch, A.E., Kunkel, S.L., Strieter, R.M. Cytokines in rheumatoid arthritis. J Invest Med. 43: 28-38, 1995
  25. F. Goldblatt and D.A. Isenberg. New therapies for rheumatoid arthritis. Clinical and Experimental Immunology. 140: 195-204, 2005 https://doi.org/10.1111/j.1365-2249.2005.02744.x
  26. 痺論. 黃帝內經 素問釋解. 서울, 一中社, p 328, 1998
  27. 한방재활의과학회. 한방재활의과학. 서울, 군자출판사, p 78, 2003
  28. 강인수. 비증치료의 용약에 대한 소고. 대한한의학회지 11(1):245-252, 1990
  29. 제정진. 血府逐瘀湯이 Adjuvant 유발 관절염에 미치는 영향. 경희대학교 대학원, 석사, 1993
  30. Trentham, D.E., Townes, A.S., Kang, A.H. Autoimmunity to type ll collagen；An experimental model of arthritis. J Exp Med. 145: 857-868, 1977 https://doi.org/10.1084/jem.146.3.857
  31. A.J. QUAYLE, P. CHOMARAT, P. MIOSSEC, J. KJELDSEN-KRAGH and Oslash, F. and Oslash RRE, J.B. NATVIG. Rheumatoid Inflammatory T-Cell Clones express mostly Th1 but also Th2 and Mixed (Th0-Like) Cytokine Patterns. Scandinavian Journal of Immunology. 38(1):75-82, 1993 https://doi.org/10.1111/j.1365-3083.1993.tb01696.x
  32. Adorini, I., Guery, J.C., Trembleau, S. Manipulation of the Th1/Th2 cell balance an approach to treat human autoimmune diseases? Autoimmunity. 23: 53-68, 1996 https://doi.org/10.3109/08916939608995329
  33. K.S. Nandakumar, J. Backlund, M. Vestberg, R. Holmdahl. Collagen type II (C ll)-specific antibodies induce arthritis in the absence of Tor B cells but the arthritis progression is enhanced by C ll-reactive T cells, Arthritis Res. Ther. 6: 544-550, 2004 https://doi.org/10.1186/ar1217
  34. K.S. Nandakumar, R. Holmdahl, Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis, J. Immunol. Methods. 304: 126-136, 2005 https://doi.org/10.1016/j.jim.2005.06.017
  35. Smiley, J.D., Moore, S.E.J. Molecular mechanisms of autoimmunity. American journal of Medical Science. 295: 478-496, 1988 https://doi.org/10.1097/00000441-198805000-00014
  36. Morgan Flierman, R., van Duivenvoorde, L.M., Witteveen, H.J., van Ewijk, W., van Laar, J.M., de Vries, R.R., Toes, R.E. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25 regulatory T cells. Arthritis and Rheumatism. 52: 2212-2221, 2005 https://doi.org/10.1002/art.21195
  37. Hori, S., Takahashi, T., Sakaguchi, S. Control of autoimmunity by naturally arising regulatory CD4+ T cells. Advances in Immunology. 81: 331, 2003 https://doi.org/10.1016/S0065-2776(03)81008-8
  38. Kai, H., Shibuya, K., Wang, Y., Kameta, H., Kameyama, T., Tahara-Hanaoka, S., Miyamoto, A., Honda, S., Matsumoto, I., Koyama, A., Sumida, T., Shibuya, A. Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice. Immunology. 118(2):233-239, 2006 https://doi.org/10.1111/j.1365-2567.2006.02361.x
  39. Gonzalez-Rey, E., Chorny, A., Varela, N., O'Valle, F., Delgado, M. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells. Arthritis Rheum. 56(2):531-543, 2007 https://doi.org/10.1002/art.22394
  40. Gerard, E., Kaiko Jay, C. Horvat, Kenneth, W. Beagley and Philip M. Hansbro. Immunological decision-making how does the immune system decide to mount a helper T-cell response? Immunology. 123(3):326-338, 2007
  41. Liang, S.C., Tan, X.Y., Luxenberg, D.P., Karim, R., Dunussi-Joannopoulos, K., Hansbro. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203: 2271-2279, 2006 https://doi.org/10.1084/jem.20061308
  42. Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., IIshiyama, S., et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103: 1345-1352, 1999 https://doi.org/10.1172/JCI5703
  43. Cai XY, Gommoll CPJr, Justice L, Narula SK, Fine JS. Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17. Immunol Lett. 62：51-58, 1998 https://doi.org/10.1016/S0165-2478(98)00027-3
  44. Jovanovic DV, Di Battista JA, Martel-Pelletier Jet al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol. 160：3513-3521, 1998
  45. Hwang, S.Y., Kim, J.Y., Park, M.K., Moon, Y., Kim, W.U., Kim, H.Y. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and P13-kinase/AK1-dependent pathways. Arthritis Res Ther. 6: 120-128, 2004 https://doi.org/10.1186/ar1190
  46. Ryu, S., Lee, J.H., Kim, S.I. IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes. Clin Rheumatol. 25: 16-20, 2005